McKesson Corporation $MCK Shares Acquired by Banco Bilbao Vizcaya Argentaria S.A.

Banco Bilbao Vizcaya Argentaria S.A. lifted its holdings in shares of McKesson Corporation (NYSE:MCK) by 57.8% in the third quarter, HoldingsChannel reports. The firm owned 5,452 shares of the company’s stock after acquiring an additional 1,997 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in McKesson were worth $4,199,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Brighton Jones LLC lifted its stake in McKesson by 46.3% in the 4th quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock valued at $1,438,000 after buying an additional 798 shares in the last quarter. Caxton Associates LLP purchased a new position in McKesson during the first quarter worth $233,000. Sivia Capital Partners LLC raised its holdings in shares of McKesson by 77.9% in the second quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock worth $502,000 after acquiring an additional 300 shares during the last quarter. Cetera Investment Advisers raised its holdings in shares of McKesson by 0.8% in the second quarter. Cetera Investment Advisers now owns 37,812 shares of the company’s stock worth $27,708,000 after acquiring an additional 297 shares during the last quarter. Finally, Avantax Advisory Services Inc. lifted its position in shares of McKesson by 7.6% in the second quarter. Avantax Advisory Services Inc. now owns 4,556 shares of the company’s stock valued at $3,339,000 after acquiring an additional 320 shares in the last quarter. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts recently commented on MCK shares. Raymond James Financial set a $970.00 price objective on McKesson in a research note on Thursday, March 5th. TD Cowen upped their target price on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Wall Street Zen cut shares of McKesson from a “buy” rating to a “hold” rating in a research note on Saturday. JPMorgan Chase & Co. lifted their price target on shares of McKesson from $983.00 to $1,107.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Finally, Evercore reissued an “outperform” rating on shares of McKesson in a research report on Thursday, March 5th. Thirteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $960.93.

McKesson Stock Performance

McKesson stock opened at $943.43 on Tuesday. The firm has a market capitalization of $115.56 billion, a PE ratio of 27.13, a price-to-earnings-growth ratio of 1.51 and a beta of 0.38. McKesson Corporation has a one year low of $637.00 and a one year high of $999.00. The stock’s 50 day moving average price is $896.29 and its 200 day moving average price is $828.19.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.19 by $0.15. The company had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. McKesson’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter last year, the company earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be given a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s payout ratio is presently 9.43%.

Insiders Place Their Bets

In other news, Director Maria Martinez sold 349 shares of the stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $939.87, for a total transaction of $328,014.63. Following the completion of the transaction, the director directly owned 301 shares in the company, valued at approximately $282,900.87. This represents a 53.69% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Thomas L. Rodgers sold 276 shares of the firm’s stock in a transaction that occurred on Monday, January 5th. The stock was sold at an average price of $816.18, for a total transaction of $225,265.68. Following the sale, the executive vice president directly owned 2,268 shares of the company’s stock, valued at $1,851,096.24. The trade was a 10.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 3,868 shares of company stock valued at $3,743,820. Insiders own 0.08% of the company’s stock.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.